Europe’s medical devices industry saw a rise of 27.3% in deal activity during May 2019, when compared with the last 12-month average, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
A total of 28 medical devices industry deals worth $148.53m were announced for the region in May 2019, against the 12-month average of 22 deals.
Of all the deal types, venture financing saw most activity in May 2019 with 19 transactions, representing a 67.9% share for the region.
In second place was private equity with six deals, followed by M&A deals with three transactions, respectively capturing a 21.4% and 10.7% share of the overall deal activity for the month.
In terms of value of deals, venture financing was the leading category in Europe’s medical devices industry with $109.87m, while private equity and M&A deals totalled $35.54m and $3.12m, respectively.
Europe medical devices industry deals in May 2019: Top deals
The top five medical devices deals accounted for 73.3% of the overall value during May 2019.
The combined value of the top five medical devices deals stood at $108.93m, against the overall value of $148.53m recorded for the month. The top announced medical devices deal tracked by GlobalData in May 2019 was BPI France, IDInvest Partners, Illumina Ventures, Kurma Partners, Life Sciences Partners, Merck Ventures and Sofinnova Partners’ $38.5m venture financing of DNA Script.
In second place was the $29.9m private equity deal with Medtrade Products by Tikehau Capital Partners and in third place was Capricorn Venture Partners, Forestay Capital and Optum Ventures’ $18m venture financing of Icometrix.
The $12.66m venture financing of Visible Patient by Alsace Creation and CM-CIC Innovation and BOM Brabant Ventures, btov Partners, Panakes Partners and Sioux Tech Fund’s venture financing of SamanTree Medical for $9.87m held fourth and fifth positions, respectively.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.